AVITA Medical, Inc. (RCEL)

AVITA Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Oct 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jun 30, 2021
Market Capitalization	167	338	352	166	299	511
Market Cap Growth	-41.47%	-4.00%	111.74%	-44.28%	-41.54%	-22.10%
Enterprise Value	196	339	295	79	190	398
Last Close Price	5.47	12.80	13.72	6.60	11.98	20.52
PS Ratio	1.92	5.26	7.03	4.83	9.04	17.47
PB Ratio	-	75.17	7.18	1.96	2.85	4.42
P/TBV Ratio	-	-	7.25	1.97	2.87	4.43
EV/Sales Ratio	2.61	5.28	5.88	2.30	5.77	13.60
Debt / Equity Ratio	-3.46	10.22	0.87	0.01	0.02	0.01
Asset Turnover	1.03	0.67	0.48	0.32	-	0.28
Inventory Turnover	1.65	1.41	2.02	2.84	-	4.29
Quick Ratio	0.43	2.37	7.35	7.86	9.70	16.05
Current Ratio	0.58	2.83	7.88	8.18	10.07	16.42
Return on Equity (ROE)	-935.73%	-230.96%	-52.89%	-28.16%	-	-28.27%
Return on Assets (ROA)	-40.03%	-36.97%	-25.40%	-16.05%	-	-15.95%
Return on Capital (ROIC)	-58.02%	-49.84%	-30.10%	-17.91%	-	-17.27%
Earnings Yield	-30.92%	-18.29%	-10.04%	-16.03%	-8.42%	-5.21%
FCF Yield	-25.15%	-17.18%	-11.18%	-11.75%	-6.20%	-5.25%
Buyback Yield / Dilution	-2.60%	-2.18%	-1.32%	-2.64%	-7.42%	-11.75%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q